Federal contract award

HT942523C0049

KERICURE, INC. DHA SBIR PHASE III CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeDEFENSE HEALTH AGENCY
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$3.1M
Current contract value$3.1M
Potential contract value / ceiling$3.1M
Start dateSep 25, 2023
Current end dateJan 24, 2027
Potential end dateJan 24, 2027
Latest award activityMay 29, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 29, 2026P00004$0CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE
Apr 29, 2026P00003$0CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE
Dec 18, 2024P00002$0KERICURE DHA SBIR PHASE III CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE
Dec 11, 2023P00001$0KERICURE, INC. DHA SBIR PHASE III CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE
Sep 20, 20230$3.1MKERICURE, INC. DHA SBIR PHASE III CLINICAL VALIDATION OF A PORTABLE, RUGGEDIZED ANTIMICROBIAL WOUND DRESSING IN MANAGEMENT OF LARGE SURFACE AREA BURNS FOR PROLONGED FIELD CARE AND LONG-TERM CARE

Estimated positioning window

Oct 25, 2026 – Jan 23, 2027

Recompete signal:
70/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 70/100. Available recorded signals: 65 points.

Contract end 2027-01-24 (91 days from calculation)
+35 points
4 historical awards in this buyer and category group
+15 points
5 recorded award transactions
+10 points
Latest award action: 2026-05-29
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.